Aurigene Discovery Technologies Limited

This early-stage study tested a new drug called AUR106 in 21 adults with advanced solid tumors like lung, stomach, bladder, kidney, colon, or esophageal cancer that had come back. The main goals were to find a safe dose and check for side effects. The study was stopped early, so …

This early-stage study tested an experimental oral drug called AUR105 in 17 adults with advanced solid tumors or lymphomas that had come back after prior treatment. The goal was to check safety, find the right dose, and see how the body processes the drug. The study was terminate…

This early-phase study tested a new drug called AUR103 Calcium in 27 adults with advanced solid tumors, acute myeloid leukemia, myelodysplastic syndromes, or non-Hodgkin lymphoma who had no other treatment options. The goal was to find the best dose and check safety. The study wa…

This trial tested a new drug, AUR103 calcium, combined with standard treatments (trastuzumab and chemotherapy) for people with advanced HER2-positive stomach or gastroesophageal junction cancer. The study was in early phases (1b and 2) and aimed to find safe doses and check if th…

This study tested a new drug called AUR 109 in 29 people with colorectal, ovarian, or kidney cancer who had already tried other treatments. The goal was to see if different doses could shrink tumors and how safe the drug was. The trial was stopped early, so results are limited.

This early-stage study tested an experimental oral drug called AUR104 in adults with certain types of blood cancers that had come back or stopped responding to treatment. The main goal was to check the drug's safety and find the right dose. Only 9 people took part before the stud…